UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3

PloS one, 2012-01, Vol.7 (1), p.e29370-e29370

2012

Link zum Volltext

Verfügbarkeit prüfen

A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis

PloS one, 2014, Vol.9 (4), p.e93601-e93601

2014

Link zum Volltext

Verfügbarkeit prüfen

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response

Endocrine Connections, 2019-02, Vol.8 (2), p.95-99

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized comparison of 12 or 24 weeks of peginterferon α‐2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

Hepatology (Baltimore, Md.), 2008-06, Vol.47 (6), p.1837-1845

2008

Link zum Volltext

Verfügbarkeit prüfen

PD-116 - The effects of once-weekly semaglutide on beta-cell function in subjects with type 2 diabetes

Diabetes research and clinical practice, 2016-10, Vol.120, p.S127-S128

2016

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with obesity

Diabetes research and clinical practice, 2016-10, Vol.120, p.S119-S119

2016

Link zum Volltext

Verfügbarkeit prüfen

The effects of once-weekly semaglutide on beta-cell function in subjects with type 2 diabetes

Diabetes research and clinical practice, 2016-10, Vol.120, p.S127-S128

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-89 - Semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with obesity

Diabetes research and clinical practice, 2016-10, Vol.120, p.S119-S119

2016

Link zum Volltext

Verfügbarkeit prüfen

Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2131-2139

2014

Link zum Volltext

Verfügbarkeit prüfen

Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects

American journal of physiology: Gastrointestinal and liver physiology, 2011-08, Vol.301 (2), p.G269-G277

2011

Link zum Volltext

Verfügbarkeit prüfen

PD-88 - Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity

Diabetes research and clinical practice, 2016-10, Vol.120, p.S119-S119

2016

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity

Diabetes research and clinical practice, 2016-10, Vol.120, p.S119-S119

2016

Link zum Volltext

Verfügbarkeit prüfen

Direct effects of TNF-[alpha] on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.4023

2013

Link zum Volltext

Verfügbarkeit prüfen

CA-180 - Le semaglutide entraîne une réduction de l’appétit et de l’apport énergétique à l’origine d’une perte de poids chez les sujets obèses

Diabetes & metabolism, 2017-03, Vol.43 (2), p.A110-A110

2017

Link zum Volltext

Verfügbarkeit prüfen

CA-176 - Le semaglutide améliore la glycémie post-prandiale, le métabolisme lipidique et retarde la vidange gastrique de la 1re heure chez les obèses

Diabetes & metabolism, 2017-03, Vol.43 (2), p.A109-A109

2017

Link zum Volltext

Verfügbarkeit prüfen

CAD-31 - Étude SUSTAIN 4 : efficacité et tolérance du semaglutide une fois par semaine versus insuline glargine une fois par jour chez des diabétiques de type 2 naïfs d’insuline

Diabetes & metabolism, 2017-03, Vol.43 (2), p.A48-A48

2017

Link zum Volltext

Verfügbarkeit prüfen

Le semaglutide entraîne une réduction de l’appétit et de l’apport énergétique à l’origine d’une perte de poids chez les sujets obèses

Diabetes & metabolism, 2017-03, Vol.43 (2), p.A110

2017

Link zum Volltext

Verfügbarkeit prüfen

Étude SUSTAIN 4 : efficacité et tolérance du semaglutide une fois par semaine versus insuline glargine une fois par jour chez des diabétiques de type 2 naïfs d’insuline

Diabetes & metabolism, 2017-03, Vol.43 (2), p.A48

2017

Link zum Volltext

Verfügbarkeit prüfen

Le semaglutide améliore la glycémie post-prandiale, le métabolisme lipidique et retarde la vidange gastrique de la 1 re heure chez les obèses

Diabetes & metabolism, 2017-03, Vol.43 (2), p.A109

2017

Link zum Volltext

Verfügbarkeit prüfen

Direct Effects of TNF-α on Local Fuel Metabolism and Cytokine Levels in the Placebo-Controlled, Bilaterally Infused Human Leg: Increased Insulin Sensitivity, Increased Net Protein Breakdown, and Increased IL-6 Release

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.4023-4029

2013

Link zum Volltext

Verfügbarkeit prüfen

Muscle metabolism and whole blood amino acid profile in patients with liver disease

Scandinavian journal of clinical and laboratory investigation, 2015-01, Vol.75 (8), p.674-680

2015

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide Improves Postprandial Glucose and Lipid Metabolism and Delays First-Hour Gastric Emptying in Subjects with Obesity

Canadian journal of diabetes, 2016-10, Vol.40 (5), p.S34-S35

2016

Link zum Volltext

Verfügbarkeit prüfen

96 - Semaglutide Improves Postprandial Glucose and Lipid Metabolism and Delays First-Hour Gastric Emptying in Subjects with Obesity

Canadian journal of diabetes, 2016-10, Vol.40 (5), p.S34-S35

2016

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2014-12, Vol.60 (6), p.2130-2131

2014

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2014-12, Vol.60 (6), p.2130-2131

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

ThemaHepatitis C, Chronic - Drug Therapy

KollektionOxford journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(62)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3

A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response

Randomized comparison of 12 or 24 weeks of peginterferon α‐2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

PD-116 - The effects of once-weekly semaglutide on beta-cell function in subjects with type 2 diabetes

Semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with obesity

The effects of once-weekly semaglutide on beta-cell function in subjects with type 2 diabetes

PD-89 - Semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with obesity

Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3

Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects

PD-88 - Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity

Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity

Direct effects of TNF-[alpha] on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release

CA-180 - Le semaglutide entraîne une réduction de l’appétit et de l’apport énergétique à l’origine d’une perte de poids chez les sujets obèses

CA-176 - Le semaglutide améliore la glycémie post-prandiale, le métabolisme lipidique et retarde la vidange gastrique de la 1re heure chez les obèses

CAD-31 - Étude SUSTAIN 4 : efficacité et tolérance du semaglutide une fois par semaine versus insuline glargine une fois par jour chez des diabétiques de type 2 naïfs d’insuline

Le semaglutide entraîne une réduction de l’appétit et de l’apport énergétique à l’origine d’une perte de poids chez les sujets obèses

Étude SUSTAIN 4 : efficacité et tolérance du semaglutide une fois par semaine versus insuline glargine une fois par jour chez des diabétiques de type 2 naïfs d’insuline

Le semaglutide améliore la glycémie post-prandiale, le métabolisme lipidique et retarde la vidange gastrique de la 1 re heure chez les obèses

Direct Effects of TNF-α on Local Fuel Metabolism and Cytokine Levels in the Placebo-Controlled, Bilaterally Infused Human Leg: Increased Insulin Sensitivity, Increased Net Protein Breakdown, and Increased IL-6 Release

Muscle metabolism and whole blood amino acid profile in patients with liver disease

Semaglutide Improves Postprandial Glucose and Lipid Metabolism and Delays First-Hour Gastric Emptying in Subjects with Obesity

96 - Semaglutide Improves Postprandial Glucose and Lipid Metabolism and Delays First-Hour Gastric Emptying in Subjects with Obesity

Reply

Reply

Aktive Filter

Suchergebnisse filtern